Oligonucleotides and N = 1 Therapeutics: From the Patient Perspective to Chemistry, Manufacturing, and Control

Tim Yu; Daniel O'Reilly

doi:10.1089/nat.2022.29005.tyu

Oligonucleotides and N = 1 Therapeutics: From the Patient Perspective to Chemistry, Manufacturing, and Control

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	81-82
Number of pages	2
Journal	Nucleic Acid Therapeutics
Volume	32
Issue number	2
DOIs	https://doi.org/10.1089/nat.2022.29005.tyu
State	Published - Apr 2022
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Genetics
Drug Discovery

Access to Document

10.1089/nat.2022.29005.tyu

Cite this

@article{09a0c677975643e49ca593513fd41197,

title = "Oligonucleotides and N = 1 Therapeutics: From the Patient Perspective to Chemistry, Manufacturing, and Control",

author = "Tim Yu and Daniel O'Reilly",

year = "2022",

month = apr,

doi = "10.1089/nat.2022.29005.tyu",

language = "English (US)",

volume = "32",

pages = "81--82",

journal = "Nucleic Acid Therapeutics",

issn = "2159-3337",

publisher = "Mary Ann Liebert Inc.",

number = "2",

}

TY - JOUR

T1 - Oligonucleotides and N = 1 Therapeutics

T2 - From the Patient Perspective to Chemistry, Manufacturing, and Control

AU - Yu, Tim

AU - O'Reilly, Daniel

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85129108074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85129108074&partnerID=8YFLogxK

U2 - 10.1089/nat.2022.29005.tyu

DO - 10.1089/nat.2022.29005.tyu

M3 - Editorial

C2 - 35352971

AN - SCOPUS:85129108074

SN - 2159-3337

VL - 32

SP - 81

EP - 82

JO - Nucleic Acid Therapeutics

JF - Nucleic Acid Therapeutics

IS - 2

ER -

Oligonucleotides and N = 1 Therapeutics: From the Patient Perspective to Chemistry, Manufacturing, and Control

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this